Vaccination with type-1 dendritic cells pulsed with multiple glioma-associated antigen peptides in combination with POLY-ICLC in patients with recurrent malignant glioma

被引：0
|
作者：
Okada, Hideho [1 ]
Lieberman, Frank [1 ]
Kalinski, Pawel [1 ]
Zhu, Xinmei [1 ]
Lunsford, L. Dade [1 ]
Kassam, Amin [1 ]
Mintz, Arlan
Bartlett, David [1 ]
Brown, Charles
Zeh, Herbert [1 ]
Whiteside, Theresa [1 ]
Butterfield, Lisa [1 ]
Hamilton, Ronald [1 ]
Salazar, Andres [2 ]
Pollack, Ian [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Oncovir Inc, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 45 条
  • [21] INDUCTION OF ROBUST TYPE-1 CD8+ T-CELL RESPONSES IN WHO GRADE II LOW-GRADE GLIOMA PATIENTS RECEIVING PEPTIDE-BASED VACCINES IN COMBINATION WITH POLY-ICLC
    Okada, Hideho
    Butterfield, Lisa
    Hamilton, Ronald
    Ahn, Brian
    Kohanbash, Gary
    Drappatz, Jan
    Engh, Johnathan
    Amankulor, Nduka
    Lively, Mark
    Chan, Michael
    Salazar, Andres
    Shaw, Edward
    Potter, Douglas
    Lieberman, Frank
    NEURO-ONCOLOGY, 2014, 16
  • [22] Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Panigrahy, Ashok
    Normolle, Daniel P.
    Connelly, Angela K.
    Dibridge, Sharon
    Mason, Gary
    Whiteside, Theresa L.
    Okada, Hideho
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 517 - 527
  • [23] Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study
    Ian F. Pollack
    Regina I. Jakacki
    Lisa H. Butterfield
    Ronald L. Hamilton
    Ashok Panigrahy
    Daniel P. Normolle
    Angela K. Connelly
    Sharon Dibridge
    Gary Mason
    Theresa L. Whiteside
    Hideho Okada
    Journal of Neuro-Oncology, 2016, 130 : 517 - 527
  • [24] PRELIMINARY RESULTS OF A PILOT STUDY TO EVALUATE THE EFFECTS OF VACCINATIONS WITH HLA-A2-RESTRICTED GLIOMA ANTIGEN PEPTIDES IN COMBINATION WITH POLY-ICLC FOR CHILDREN WITH NEWLY DIAGNOSED MALIGNANT BRAINSTEM GLIOMAS, NONBRAINSTEM HIGH-GRADE GLIOMAS, OR RECURRENT UNRESECTABLE GRADE GLIOMAS
    Pollack, Ian
    Jakacki, Regina
    Butterfield, Lisa
    Salazar, Andres
    Okada, Hideho
    NEURO-ONCOLOGY, 2011, 13 : I3 - I3
  • [25] VACCINATION OF DENDRITIC CELLS LOADED BY ELECTROPORATION WITH AUTOLOGOUS TUMOR LYSATE FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: EVALUATION OF SAFETY AND IMMUNE RESPONSE
    Kanemura, Yonehiro
    Sumida, Miho
    Yoshioka, Ema
    Yamamoto, Atsuyo
    Kanematsu, Daisuke
    Takada, Ai
    Nonaka, Masahiro
    Nakajima, Shin
    Goto, Shigenori
    Kamigaki, Takashi
    Takahara, Masashi
    Maekawa, Ryuji
    Shofuda, Tomoko
    Moriuchi, Shusuke
    Yamasaki, Mami
    NEURO-ONCOLOGY, 2013, 15 : 70 - 70
  • [26] RESULTS OF A PILOT STUDY TO EVALUATE THE EFFECTS OF VACCINATIONS WITH HLA-A2-RESTRICTED GLIOMA ANTIGEN-PEPTIDES IN COMBINATION WITH POLY-ICLC FOR CHILDREN WITH NEWLY DIAGNOSED MALIGNANT BRAIN STEM GLIOMAS, NON-BRAINSTEM HIGH-GRADE GLIOMAS, OR RECURRENT UNRESECTABLE GLIOMAS
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Okada, Hideho
    NEURO-ONCOLOGY, 2011, 13 : 35 - 35
  • [27] Vaccination of recurrent glioma patients with tumor lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase 1/2 trial
    Homa, J
    Yamanaka, R
    Abe, T
    Narita, M
    Takahashi, M
    Tanaka, R
    NEURO-ONCOLOGY, 2005, 7 (03) : 368 - 369
  • [28] α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
    Yasuto Akiyama
    Chie Oshita
    Akiko Kume
    Akira Iizuka
    Haruo Miyata
    Masaru Komiyama
    Tadashi Ashizawa
    Mika Yagoto
    Yoshiaki Abe
    Koichi Mitsuya
    Reiko Watanabe
    Takashi Sugino
    Ken Yamaguchi
    Yoko Nakasu
    BMC Cancer, 12
  • [29] α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
    Akiyama, Yasuto
    Oshita, Chie
    Kume, Akiko
    Iizuka, Akira
    Miyata, Haruo
    Komiyama, Masaru
    Ashizawa, Tadashi
    Yagoto, Mika
    Abe, Yoshiaki
    Mitsuya, Koichi
    Watanabe, Reiko
    Sugino, Takashi
    Yamaguchi, Ken
    Nakasu, Yoko
    BMC CANCER, 2012, 12
  • [30] Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
    Yu, JS
    Wheeler, CJ
    Zeltzer, PM
    Ying, H
    Finger, DN
    Lee, PK
    Yong, WH
    Incardona, F
    Thompson, RC
    Riedinger, MS
    Zhang, WX
    Prins, RM
    Black, KL
    CANCER RESEARCH, 2001, 61 (03) : 842 - 847
12345